ABEONA THERAPEUTICS INC. ABEO Cash Flow

Abeona therapeutics inc. (ABEO)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net loss
-48,159	-16,431	-17,372	-23,924	-18,555	-17,479	-16,419	-12,243	-10,530	-8,450	-5,343	-8,279	-5,247	-7,002	-2,624	-6,703	-5,544	-2,340	-6,073	-4,113	-2,000	-11,943	-1,469	-12,507	-859	-1,075	-157	1,600	4,081	19,827	-14,867	-10,600	-4,892	281	350	-1,264	-1,899
Adjustments to reconcile net loss to cash used in operating activities:
Licensed technology impairment charge
32,916	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) on change in fair value of derivative-warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	131	168	219	-247	0	64	431	741	-	-	-	-
Loss on change in fair value of derivative-preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11,300	-700	-11,693	583	-461	421	3,270	4,780	21,000	-13,900	-9,410	-2,460	-	-	-	-
Gain on change in fair value of derivative - warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,138	939	1,235
Loss on change in fair value of derivative - preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	-403	823
Warrant extension expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,316	0	0	0	0
Depreciation and amortization
2,065	2,072	2,032	2,057	1,658	1,391	505	290	174	146	138	207	250	248	222	181	174	150	151	132	118	9	1	1	0	1	1	0	1	328	18	19	54	57	56	59	61
Stock option-based compensation expense
1,256	1,731	1,826	1,678	2,103	1,106	2,499	2,673	1,900	1,117	792	1,243	1,492	935	917	1,385	1,592	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted stock-based compensation expense
464	551	98	78	172	172	172	172	172	293	293	324	362	312	241	987	1,892	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion and interest on short-term investments
109	-	-	-	169	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of right-of-use lease assets
245	-	-	-	150	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash earnings on investments
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in operating assets and liabilities:
Receivables
-	-15	-25	2	-43	-271	305	-17	-43	-4	14	-51	24	-482	494	-132	129	-156	-59	185	109	32	-55	-1	-15	18	-203	-972	391	359	-307	-146	601	214	68	5	-972
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-150	-44	-42	-45	184	-54	-41	192	0	0
Prepaid expenses and other current assets
-416	1,478	-689	-1,029	-430	1,827	38	-155	-643	973	895	404	308	-1	-50	5	-114	178	-85	96	98	-76	-14	8	5	-12	-203	50	-9	223	-16	1	4	12	-48	26	-21
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-42	6	40	0	20	0	9	-	-	-	0	-	-	-	-	-4	-5	-4	-4	-5	-4	28	-4
Right-of-use lease assets and other assets
-	-	-	-	-	-	-2	42	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable, accrued expenses and lease liabilities
2,926	-832	5,533	-3,904	910	271	-4,548	128	-3,516	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-1,580	2,154	-2,231	1,781	-192	1,063	167	-93	-350	527	-1,258	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock option compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	224	146	172	192	795	85	26	251	77	83	85	108	114	299	344	242	181
Stock issued to directors, employees and consultants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,892	-1,892	-1,036	-32	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued to directors and employees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-68	-33	-37	-29	-	0	0	-302	-	-	-	-
Stock issued to directors and employees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Stock issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	68	171	75	87	58	84	132	75	3	11	87	10	24	10	13	30	-98	225	229	246
Contingent consideration milestone
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-2,000	0	-591	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-734	290	265	212	157	-599	-1,080	346	-67	-63	532	165	126	-36	55	-92
Interest on dividends payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	169	164	137	122	97	96	43	43	-	102	86	86	-	-	-	-
Dividends payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74	73	63	61
Accrued interest payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-19	-245	83	83	68	-495	293	106
Deferred revenue
-	-	-	-	-	-	-	-	-	2,461	-150	-151	-151	-150	-151	-150	-151	-151	-150	-151	-150	-151	-151	-150	103	-144	-144	3,216	-62	-63	-61	40	-512	-71	-936	-87	-86
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,116	-2,516	-2,877	-2,512	-1,871	-3,163	-1,102	-140	-244	-125	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-13,232	-14,246	-18,254	-15,242	-15,078	-16,967	-9,040	-9,022	-4,082	-5,046	-6,770	-4,982	-5,857	-	-	-	-	-	-	-	-	-	-	-	-	-	-916	1,737	-346	-1,616	-482	-775	-1,082	-1,964	-2,997	-1,811	-837
Cash flows from investing activities:
Capital expenditures
479	122	937	4,024	1,226	663	1,657	3,421	3,502	704	72	10	74	18	148	126	227	267	27	5	9	0	0	0	0	-	-	-	-	-2	0	2	13	0	1	17	22
Proceeds from maturities of short-term investments
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of short-term investments
75,392	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from maturities of short-term investments
-	-	-	-	24,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of short-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	400	-	-250	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-75,871	-946	19,228	18,920	22,774	2,119	-10,430	-73,273	-3,502	-704	-72	-10	-74	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	0	-2	-13	0	-1	-17	-22
Cash flows from financing activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-126	-227	-267	-27	3,692	-9	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	556	0	385	28	-1	79	481	1,685	251	8	85	0	350	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	150	0	0	15,411	20,641	-400	12,457	250	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	96,527	4,340	13,007	28	-1	3,079	570	1,829	87,258	5,060	84	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (decrease) increase in cash, cash equivalents and restricted cash
-89,103	81,335	5,314	16,685	7,724	-14,849	-16,391	-81,725	-5,755	81,508	-1,782	-4,908	-5,930	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental cash flow information:
Net increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,118	-3,092	-2,743	-3,144	12,872	22,462	-3,572	11,355	110	-244	-125	-475	-899	1,748	-346	290	-482	-777	-1,095	1,112	-2,998	-1,828	-859
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	0	0	0	0	0	0	0	58	330	0	0	1,380	-660	0	0
Cash paid for interest
-	-	-	-	-	2	3	3	3	1	2	3	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares issued for dividends on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	9	13	-	-	-	-
Preferred stock dividends in dividends payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	684	740	726	725	696	742	733	727	676	444	439	440	-	-	-	-
Shares issued for dividends on preferred stock (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	1
Preferred stock dividends in dividends payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-447	-442	-438
Dollar Five Warrant
Proceeds from exercise of $5.00 warrants
-	-	-	-	-	-	-	89	144	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-